Global DTIs for Injection Market Insights, Forecast to 2030

TABLE OF CONTENTS

1 Study Coverage

• 1.1 DTIs for Injection Product Introduction
• 1.2 Market by Type
  • 1.2.1 Global DTIs for Injection Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
  • 1.2.2 Argatroban
  • 1.2.3 Bivalirudin
  • 1.2.4 Other
• 1.3 Market by Application
  • 1.3.1 Global DTIs for Injection Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
  • 1.3.2 Deep Vein Thrombosis
  • 1.3.3 Pulmonary Embolism
  • 1.3.4 Atrial Fibrillation
  • 1.3.5 Other
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 Executive Summary

• 2.1 Global DTIs for Injection Revenue Estimates and Forecasts 2019-2030
• 2.2 Global DTIs for Injection Revenue by Region
  • 2.2.1 Global DTIs for Injection Revenue by Region: 2019 VS 2023 VS 2030
  • 2.2.2 Global DTIs for Injection Revenue by Region (2019-2024)
  • 2.2.3 Global DTIs for Injection Revenue by Region (2025-2030)
  • 2.2.4 Global DTIs for Injection Revenue Market Share by Region (2019-2030)
• 2.3 Global DTIs for Injection Sales Estimates and Forecasts 2019-2030
• 2.4 Global DTIs for Injection Sales by Region
  • 2.4.1 Global DTIs for Injection Sales by Region: 2019 VS 2023 VS 2030
  • 2.4.2 Global DTIs for Injection Sales by Region (2019-2024)
  • 2.4.3 Global DTIs for Injection Sales by Region (2025-2030)
  • 2.4.4 Global DTIs for Injection Sales Market Share by Region (2019-2030)
• 2.5 US & Canada
• 2.6 Europe
• 2.7 China
• 2.8 Asia (excluding China)
• 2.9 Middle East, Africa and Latin America

3 Competition by Manufacturers

• 3.1 Global DTIs for Injection Sales by Manufacturers
  • 3.1.1 Global DTIs for Injection Sales by Manufacturers (2019-2024)
  • 3.1.2 Global DTIs for Injection Sales Market Share by Manufacturers (2019-2024)
  • 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of DTIs for Injection in 2023
• 3.2 Global DTIs for Injection Revenue by Manufacturers
  • 3.2.1 Global DTIs for Injection Revenue by Manufacturers (2019-2024)
  • 3.2.2 Global DTIs for Injection Revenue Market Share by Manufacturers (2019-2024)
  • 3.2.3 Global Top 10 and Top 5 Companies by DTIs for Injection Revenue in 2023
• 3.3 Global Key Players of DTIs for Injection, Industry Ranking, 2021 VS 2022
• 3.4 Global DTIs for Injection Sales Price by Manufacturers (2019-2024)
• 3.5 Analysis of Competitive Landscape
  • 3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
  • 3.5.2 Global DTIs for Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
• 3.6 Global Key Manufacturers of DTIs for Injection, Manufacturing Base Distribution and Headquarters
• 3.7 Global Key Manufacturers of DTIs for Injection, Product Offered and Application
• 3.8 Global Key Manufacturers of DTIs for Injection, Date of Enter into This Industry
• 3.9 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Global DTIs for Injection Sales by Type
  • 4.1.1 Global DTIs for Injection Historical Sales by Type (2019-2024)
  • 4.1.2 Global DTIs for Injection Forecasted Sales by Type (2025-2030)
  • 4.1.3 Global DTIs for Injection Sales Market Share by Type (2019-2030)
• 4.2 Global DTIs for Injection Revenue by Type
  • 4.2.1 Global DTIs for Injection Historical Revenue by Type (2019-2024)
  • 4.2.2 Global DTIs for Injection Forecasted Revenue by Type (2025-2030)
  • 4.2.3 Global DTIs for Injection Revenue Market Share by Type (2019-2030)
• 4.3 Global DTIs for Injection Price by Type
  • 4.3.1 Global DTIs for Injection Price by Type (2019-2024)
  • 4.3.2 Global DTIs for Injection Price Forecast by Type (2025-2030)

5 Market Size by Application

• 5.1 Global DTIs for Injection Sales by Application
  • 5.1.1 Global DTIs for Injection Historical Sales by Application (2019-2024)
  • 5.1.2 Global DTIs for Injection Forecasted Sales by Application (2025-2030)
  • 5.1.3 Global DTIs for Injection Sales Market Share by Application (2019-2030)
• 5.2 Global DTIs for Injection Revenue by Application
  • 5.2.1 Global DTIs for Injection Historical Revenue by Application (2019-2024)
  • 5.2.2 Global DTIs for Injection Forecasted Revenue by Application (2025-2030)
  • 5.2.3 Global DTIs for Injection Revenue Market Share by Application (2019-2030)
• 5.3 Global DTIs for Injection Price by Application
  • 5.3.1 Global DTIs for Injection Price by Application (2019-2024)
  • 5.3.2 Global DTIs for Injection Price Forecast by Application (2025-2030)

6 US & Canada

• 6.1 US & Canada DTIs for Injection Market Size by Type
  • 6.1.1 US & Canada DTIs for Injection Sales by Type (2019-2030)
  • 6.1.2 US & Canada DTIs for Injection Revenue by Type (2019-2030)
• 6.2 US & Canada DTIs for Injection Market Size by Application
  • 6.2.1 US & Canada DTIs for Injection Sales by Application (2019-2030)
  • 6.2.2 US & Canada DTIs for Injection Revenue by Application (2019-2030)
• 6.3 US & Canada DTIs for Injection Market Size by Country
  • 6.3.1 US & Canada DTIs for Injection Revenue by Country: 2019 VS 2023 VS 2030
  • 6.3.2 US & Canada DTIs for Injection Revenue by Country (2019-2030)
  • 6.3.3 US & Canada DTIs for Injection Sales by Country (2019-2030)
  • 6.3.4 US
  • 6.3.5 Canada

7 Europe

• 7.1 Europe DTIs for Injection Market Size by Type
  • 7.1.1 Europe DTIs for Injection Sales by Type (2019-2030)
  • 7.1.2 Europe DTIs for Injection Revenue by Type (2019-2030)
• 7.2 Europe DTIs for Injection Market Size by Application
  • 7.2.1 Europe DTIs for Injection Sales by Application (2019-2030)
  • 7.2.2 Europe DTIs for Injection Revenue by Application (2019-2030)
• 7.3 Europe DTIs for Injection Market Size by Country
  • 7.3.1 Europe DTIs for Injection Revenue by Country: 2019 VS 2023 VS 2030
  • 7.3.2 Europe DTIs for Injection Revenue by Country (2019-2030)
  • 7.3.3 Europe DTIs for Injection Sales by Country (2019-2030)
  • 7.3.4 Germany
  • 7.3.5 France
  • 7.3.6 U.K.
  • 7.3.7 Italy
  • 7.3.8 Russia

8 China

• 8.1 China DTIs for Injection Market Size by Type
  • 8.1.1 China DTIs for Injection Sales by Type (2019-2030)
  • 8.1.2 China DTIs for Injection Revenue by Type (2019-2030)
• 8.2 China DTIs for Injection Market Size by Application
  • 8.2.1 China DTIs for Injection Sales by Application (2019-2030)
  • 8.2.2 China DTIs for Injection Revenue by Application (2019-2030)

9 Asia (excluding China)

• 9.1 Asia DTIs for Injection Market Size by Type
  • 9.1.1 Asia DTIs for Injection Sales by Type (2019-2030)
  • 9.1.2 Asia DTIs for Injection Revenue by Type (2019-2030)
• 9.2 Asia DTIs for Injection Market Size by Application
  • 9.2.1 Asia DTIs for Injection Sales by Application (2019-2030)
  • 9.2.2 Asia DTIs for Injection Revenue by Application (2019-2030)
• 9.3 Asia DTIs for Injection Market Size by Region
  • 9.3.1 Asia DTIs for Injection Revenue by Region: 2019 VS 2023 VS 2030
  • 9.3.2 Asia DTIs for Injection Revenue by Region (2019-2030)
  • 9.3.3 Asia DTIs for Injection Sales by Region (2019-2030)
  • 9.3.4 Japan
  • 9.3.5 South Korea
  • 9.3.6 China Taiwan
  • 9.3.7 Southeast Asia
  • 9.3.8 India
  • 9.3.9 Australia

10 Middle East, Africa and Latin America

• 10.1 Middle East, Africa and Latin America DTIs for Injection Market Size by Type
  • 10.1.1 Middle East, Africa and Latin America DTIs for Injection Sales by Type (2019-2030)
  • 10.1.2 Middle East, Africa and Latin America DTIs for Injection Revenue by Type (2019-2030)
• 10.2 Middle East, Africa and Latin America DTIs for Injection Market Size by Application
  • 10.2.1 Middle East, Africa and Latin America DTIs for Injection Sales by Application (2019-2030)
  • 10.2.2 Middle East, Africa and Latin America DTIs for Injection Revenue by Application (2019-2030)
• 10.3 Middle East, Africa and Latin America DTIs for Injection Market Size by Country
  • 10.3.1 Middle East, Africa and Latin America DTIs for Injection Revenue by Country: 2019 VS 2023 VS 2030
  • 10.3.2 Middle East, Africa and Latin America DTIs for Injection Revenue by Country (2019-2030)
  • 10.3.3 Middle East, Africa and Latin America DTIs for Injection Sales by Country (2019-2030)
  • 10.3.4 Brazil
  • 10.3.5 Mexico
  • 10.3.6 Turkey
  • 10.3.7 Israel
  • 10.3.8 GCC Countries

11 Corporate Profile

• 11.1 Mitsubishi Tanabe Pharma
  • 11.1.1 Mitsubishi Tanabe Pharma Company Information
  • 11.1.2 Mitsubishi Tanabe Pharma Overview
  • 11.1.3 Mitsubishi Tanabe Pharma DTIs for Injection Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.1.4 Mitsubishi Tanabe Pharma DTIs for Injection Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.1.5 Mitsubishi Tanabe Pharma Recent Developments
• 11.2 Pfizer
  • 11.2.1 Pfizer Company Information
  • 11.2.2 Pfizer Overview
  • 11.2.3 Pfizer DTIs for Injection Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.2.4 Pfizer DTIs for Injection Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.2.5 Pfizer Recent Developments
• 11.3 Sandoz
  • 11.3.1 Sandoz Company Information
  • 11.3.2 Sandoz Overview
  • 11.3.3 Sandoz DTIs for Injection Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.3.4 Sandoz DTIs for Injection Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.3.5 Sandoz Recent Developments
• 11.4 The Medicines Company
  • 11.4.1 The Medicines Company Company Information
  • 11.4.2 The Medicines Company Overview
  • 11.4.3 The Medicines Company DTIs for Injection Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.4.4 The Medicines Company DTIs for Injection Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.4.5 The Medicines Company Recent Developments
• 11.5 Accord Healthcare
  • 11.5.1 Accord Healthcare Company Information
  • 11.5.2 Accord Healthcare Overview
  • 11.5.3 Accord Healthcare DTIs for Injection Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.5.4 Accord Healthcare DTIs for Injection Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.5.5 Accord Healthcare Recent Developments
• 11.6 Apotex
  • 11.6.1 Apotex Company Information
  • 11.6.2 Apotex Overview
  • 11.6.3 Apotex DTIs for Injection Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.6.4 Apotex DTIs for Injection Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.6.5 Apotex Recent Developments
• 11.7 Aurobindo Pharma
  • 11.7.1 Aurobindo Pharma Company Information
  • 11.7.2 Aurobindo Pharma Overview
  • 11.7.3 Aurobindo Pharma DTIs for Injection Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.7.4 Aurobindo Pharma DTIs for Injection Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.7.5 Aurobindo Pharma Recent Developments
• 11.8 GlaxoSmithKline
  • 11.8.1 GlaxoSmithKline Company Information
  • 11.8.2 GlaxoSmithKline Overview
  • 11.8.3 GlaxoSmithKline DTIs for Injection Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.8.4 GlaxoSmithKline DTIs for Injection Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.8.5 GlaxoSmithKline Recent Developments
• 11.9 Teva Pharmaceutical
  • 11.9.1 Teva Pharmaceutical Company Information
  • 11.9.2 Teva Pharmaceutical Overview
  • 11.9.3 Teva Pharmaceutical DTIs for Injection Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.9.4 Teva Pharmaceutical DTIs for Injection Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.9.5 Teva Pharmaceutical Recent Developments
• 11.10 Eugia Pharma
  • 11.10.1 Eugia Pharma Company Information
  • 11.10.2 Eugia Pharma Overview
  • 11.10.3 Eugia Pharma DTIs for Injection Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.10.4 Eugia Pharma DTIs for Injection Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.10.5 Eugia Pharma Recent Developments
• 11.11 Dr.Reddy's Laboratories
  • 11.11.1 Dr.Reddy's Laboratories Company Information
  • 11.11.2 Dr.Reddy's Laboratories Overview
  • 11.11.3 Dr.Reddy's Laboratories DTIs for Injection Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.11.4 Dr.Reddy's Laboratories DTIs for Injection Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.11.5 Dr.Reddy's Laboratories Recent Developments
• 11.12 Yangtze River Pharmaceutical
  • 11.12.1 Yangtze River Pharmaceutical Company Information
  • 11.12.2 Yangtze River Pharmaceutical Overview
  • 11.12.3 Yangtze River Pharmaceutical DTIs for Injection Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.12.4 Yangtze River Pharmaceutical DTIs for Injection Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.12.5 Yangtze River Pharmaceutical Recent Developments
• 11.13 BrightGene
  • 11.13.1 BrightGene Company Information
  • 11.13.2 BrightGene Overview
  • 11.13.3 BrightGene DTIs for Injection Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.13.4 BrightGene DTIs for Injection Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.13.5 BrightGene Recent Developments
• 11.14 Lunan Pharmaceutical
  • 11.14.1 Lunan Pharmaceutical Company Information
  • 11.14.2 Lunan Pharmaceutical Overview
  • 11.14.3 Lunan Pharmaceutical DTIs for Injection Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.14.4 Lunan Pharmaceutical DTIs for Injection Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.14.5 Lunan Pharmaceutical Recent Developments
• 11.15 CSPC Ouyi Pharmaceutical
  • 11.15.1 CSPC Ouyi Pharmaceutical Company Information
  • 11.15.2 CSPC Ouyi Pharmaceutical Overview
  • 11.15.3 CSPC Ouyi Pharmaceutical DTIs for Injection Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.15.4 CSPC Ouyi Pharmaceutical DTIs for Injection Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.15.5 CSPC Ouyi Pharmaceutical Recent Developments
• 11.16 Beijing SL Pharmaceutical
  • 11.16.1 Beijing SL Pharmaceutical Company Information
  • 11.16.2 Beijing SL Pharmaceutical Overview
  • 11.16.3 Beijing SL Pharmaceutical DTIs for Injection Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.16.4 Beijing SL Pharmaceutical DTIs for Injection Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.16.5 Beijing SL Pharmaceutical Recent Developments

12 Industry Chain and Sales Channels Analysis

• 12.1 DTIs for Injection Industry Chain Analysis
• 12.2 DTIs for Injection Key Raw Materials
  • 12.2.1 Key Raw Materials
  • 12.2.2 Raw Materials Key Suppliers
• 12.3 DTIs for Injection Production Mode & Process
• 12.4 DTIs for Injection Sales and Marketing
  • 12.4.1 DTIs for Injection Sales Channels
  • 12.4.2 DTIs for Injection Distributors
• 12.5 DTIs for Injection Customers

13 DTIs for Injection Market Dynamics

• 13.1 DTIs for Injection Industry Trends
• 13.2 DTIs for Injection Market Drivers
• 13.3 DTIs for Injection Market Challenges
• 13.4 DTIs for Injection Market Restraints

14 Key Findings in the Global DTIs for Injection Study

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
    • 15.1.1.1 Research Programs/Design
    • 15.1.1.2 Market Size Estimation
    • 15.1.1.3 Market Breakdown and Data Triangulation
  • 15.1.2 Data Source
    • 15.1.2.1 Secondary Sources
    • 15.1.2.2 Primary Sources
• 15.2 Author Details
• 15.3 Disclaimer

List of Tables

Table 1. Global DTIs for Injection Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Table 2. Major Manufacturers of Argatroban

Table 3. Major Manufacturers of Bivalirudin

Table 4. Major Manufacturers of Other

Table 5. Global DTIs for Injection Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Table 6. Global DTIs for Injection Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 7. Global DTIs for Injection Revenue by Region (2019-2024) & (US$ Million)

Table 8. Global DTIs for Injection Revenue by Region (2025-2030) & (US$ Million)

Table 9. Global DTIs for Injection Revenue Market Share by Region (2019-2024)

Table 10. Global DTIs for Injection Revenue Market Share by Region (2025-2030)

Table 11. Global DTIs for Injection Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (K Units)

Table 12. Global DTIs for Injection Sales by Region (2019-2024) & (K Units)

Table 13. Global DTIs for Injection Sales by Region (2025-2030) & (K Units)

Table 14. Global DTIs for Injection Sales Market Share by Region (2019-2024)

Table 15. Global DTIs for Injection Sales Market Share by Region (2025-2030)

Table 16. Global DTIs for Injection Sales by Manufacturers (2019-2024) & (K Units)

Table 17. Global DTIs for Injection Sales Share by Manufacturers (2019-2024)

Table 18. Global DTIs for Injection Revenue by Manufacturers (2019-2024) & (US$ Million)

Table 19. Global DTIs for Injection Revenue Market Share by Manufacturers (2019-2024)

Table 20. Global Key Players of DTIs for Injection, Industry Ranking, 2021 VS 2022 VS 2023

Table 21. DTIs for Injection Price by Manufacturers (2019-2024) & (US$/Unit)

Table 22. Global DTIs for Injection Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 23. Global DTIs for Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in DTIs for Injection as of 2023)

Table 24. Global Key Manufacturers of DTIs for Injection, Manufacturing Base Distribution and Headquarters

Table 25. Global Key Manufacturers of DTIs for Injection, Product Offered and Application

Table 26. Global Key Manufacturers of DTIs for Injection, Date of Enter into This Industry

Table 27. Mergers & Acquisitions, Expansion Plans

Table 28. Global DTIs for Injection Sales by Type (2019-2024) & (K Units)

Table 29. Global DTIs for Injection Sales by Type (2025-2030) & (K Units)

Table 30. Global DTIs for Injection Sales Share by Type (2019-2024)

Table 31. Global DTIs for Injection Sales Share by Type (2025-2030)

Table 32. Global DTIs for Injection Revenue by Type (2019-2024) & (US$ Million)

Table 33. Global DTIs for Injection Revenue by Type (2025-2030) & (US$ Million)

Table 34. Global DTIs for Injection Revenue Share by Type (2019-2024)

Table 35. Global DTIs for Injection Revenue Share by Type (2025-2030)

Table 36. DTIs for Injection Price by Type (2019-2024) & (US$/Unit)

Table 37. Global DTIs for Injection Price Forecast by Type (2025-2030) & (US$/Unit)

Table 38. Global DTIs for Injection Sales by Application (2019-2024) & (K Units)

Table 39. Global DTIs for Injection Sales by Application (2025-2030) & (K Units)

Table 40. Global DTIs for Injection Sales Share by Application (2019-2024)

Table 41. Global DTIs for Injection Sales Share by Application (2025-2030)

Table 42. Global DTIs for Injection Revenue by Application (2019-2024) & (US$ Million)

Table 43. Global DTIs for Injection Revenue by Application (2025-2030) & (US$ Million)

Table 44. Global DTIs for Injection Revenue Share by Application (2019-2024)

Table 45. Global DTIs for Injection Revenue Share by Application (2025-2030)

Table 46. DTIs for Injection Price by Application (2019-2024) & (US$/Unit)

Table 47. Global DTIs for Injection Price Forecast by Application (2025-2030) & (US$/Unit)

Table 48. US & Canada DTIs for Injection Sales by Type (2019-2024) & (K Units)

Table 49. US & Canada DTIs for Injection Sales by Type (2025-2030) & (K Units)

Table 50. US & Canada DTIs for Injection Revenue by Type (2019-2024) & (US$ Million)

Table 51. US & Canada DTIs for Injection Revenue by Type (2025-2030) & (US$ Million)

Table 52. US & Canada DTIs for Injection Sales by Application (2019-2024) & (K Units)

Table 53. US & Canada DTIs for Injection Sales by Application (2025-2030) & (K Units)

Table 54. US & Canada DTIs for Injection Revenue by Application (2019-2024) & (US$ Million)

Table 55. US & Canada DTIs for Injection Revenue by Application (2025-2030) & (US$ Million)

Table 56. US & Canada DTIs for Injection Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 57. US & Canada DTIs for Injection Revenue by Country (2019-2024) & (US$ Million)

Table 58. US & Canada DTIs for Injection Revenue by Country (2025-2030) & (US$ Million)

Table 59. US & Canada DTIs for Injection Sales by Country (2019-2024) & (K Units)

Table 60. US & Canada DTIs for Injection Sales by Country (2025-2030) & (K Units)

Table 61. Europe DTIs for Injection Sales by Type (2019-2024) & (K Units)

Table 62. Europe DTIs for Injection Sales by Type (2025-2030) & (K Units)

Table 63. Europe DTIs for Injection Revenue by Type (2019-2024) & (US$ Million)

Table 64. Europe DTIs for Injection Revenue by Type (2025-2030) & (US$ Million)

Table 65. Europe DTIs for Injection Sales by Application (2019-2024) & (K Units)

Table 66. Europe DTIs for Injection Sales by Application (2025-2030) & (K Units)

Table 67. Europe DTIs for Injection Revenue by Application (2019-2024) & (US$ Million)

Table 68. Europe DTIs for Injection Revenue by Application (2025-2030) & (US$ Million)

Table 69. Europe DTIs for Injection Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 70. Europe DTIs for Injection Revenue by Country (2019-2024) & (US$ Million)

Table 71. Europe DTIs for Injection Revenue by Country (2025-2030) & (US$ Million)

Table 72. Europe DTIs for Injection Sales by Country (2019-2024) & (K Units)

Table 73. Europe DTIs for Injection Sales by Country (2025-2030) & (K Units)

Table 74. China DTIs for Injection Sales by Type (2019-2024) & (K Units)

Table 75. China DTIs for Injection Sales by Type (2025-2030) & (K Units)

Table 76. China DTIs for Injection Revenue by Type (2019-2024) & (US$ Million)

Table 77. China DTIs for Injection Revenue by Type (2025-2030) & (US$ Million)

Table 78. China DTIs for Injection Sales by Application (2019-2024) & (K Units)

Table 79. China DTIs for Injection Sales by Application (2025-2030) & (K Units)

Table 80. China DTIs for Injection Revenue by Application (2019-2024) & (US$ Million)

Table 81. China DTIs for Injection Revenue by Application (2025-2030) & (US$ Million)

Table 82. Asia DTIs for Injection Sales by Type (2019-2024) & (K Units)

Table 83. Asia DTIs for Injection Sales by Type (2025-2030) & (K Units)

Table 84. Asia DTIs for Injection Revenue by Type (2019-2024) & (US$ Million)

Table 85. Asia DTIs for Injection Revenue by Type (2025-2030) & (US$ Million)

Table 86. Asia DTIs for Injection Sales by Application (2019-2024) & (K Units)

Table 87. Asia DTIs for Injection Sales by Application (2025-2030) & (K Units)

Table 88. Asia DTIs for Injection Revenue by Application (2019-2024) & (US$ Million)

Table 89. Asia DTIs for Injection Revenue by Application (2025-2030) & (US$ Million)

Table 90. Asia DTIs for Injection Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 91. Asia DTIs for Injection Revenue by Region (2019-2024) & (US$ Million)

Table 92. Asia DTIs for Injection Revenue by Region (2025-2030) & (US$ Million)

Table 93. Asia DTIs for Injection Sales by Region (2019-2024) & (K Units)

Table 94. Asia DTIs for Injection Sales by Region (2025-2030) & (K Units)

Table 95. Middle East, Africa and Latin America DTIs for Injection Sales by Type (2019-2024) & (K Units)

Table 96. Middle East, Africa and Latin America DTIs for Injection Sales by Type (2025-2030) & (K Units)

Table 97. Middle East, Africa and Latin America DTIs for Injection Revenue by Type (2019-2024) & (US$ Million)

Table 98. Middle East, Africa and Latin America DTIs for Injection Revenue by Type (2025-2030) & (US$ Million)

Table 99. Middle East, Africa and Latin America DTIs for Injection Sales by Application (2019-2024) & (K Units)

Table 100. Middle East, Africa and Latin America DTIs for Injection Sales by Application (2025-2030) & (K Units)

Table 101. Middle East, Africa and Latin America DTIs for Injection Revenue by Application (2019-2024) & (US$ Million)

Table 102. Middle East, Africa and Latin America DTIs for Injection Revenue by Application (2025-2030) & (US$ Million)

Table 103. Middle East, Africa and Latin America DTIs for Injection Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 104. Middle East, Africa and Latin America DTIs for Injection Revenue by Country (2019-2024) & (US$ Million)

Table 105. Middle East, Africa and Latin America DTIs for Injection Revenue by Country (2025-2030) & (US$ Million)

Table 106. Middle East, Africa and Latin America DTIs for Injection Sales by Country (2019-2024) & (K Units)

Table 107. Middle East, Africa and Latin America DTIs for Injection Sales by Country (2025-2030) & (K Units)

Table 108. Mitsubishi Tanabe Pharma Company Information

Table 109. Mitsubishi Tanabe Pharma Description and Major Businesses

Table 110. Mitsubishi Tanabe Pharma DTIs for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 111. Mitsubishi Tanabe Pharma DTIs for Injection Product Model Numbers, Pictures, Descriptions and Specifications

Table 112. Mitsubishi Tanabe Pharma Recent Developments

Table 113. Pfizer Company Information

Table 114. Pfizer Description and Major Businesses

Table 115. Pfizer DTIs for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 116. Pfizer DTIs for Injection Product Model Numbers, Pictures, Descriptions and Specifications

Table 117. Pfizer Recent Developments

Table 118. Sandoz Company Information

Table 119. Sandoz Description and Major Businesses

Table 120. Sandoz DTIs for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 121. Sandoz DTIs for Injection Product Model Numbers, Pictures, Descriptions and Specifications

Table 122. Sandoz Recent Developments

Table 123. The Medicines Company Company Information

Table 124. The Medicines Company Description and Major Businesses

Table 125. The Medicines Company DTIs for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 126. The Medicines Company DTIs for Injection Product Model Numbers, Pictures, Descriptions and Specifications

Table 127. The Medicines Company Recent Developments

Table 128. Accord Healthcare Company Information

Table 129. Accord Healthcare Description and Major Businesses

Table 130. Accord Healthcare DTIs for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 131. Accord Healthcare DTIs for Injection Product Model Numbers, Pictures, Descriptions and Specifications

Table 132. Accord Healthcare Recent Developments

Table 133. Apotex Company Information

Table 134. Apotex Description and Major Businesses

Table 135. Apotex DTIs for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 136. Apotex DTIs for Injection Product Model Numbers, Pictures, Descriptions and Specifications

Table 137. Apotex Recent Developments

Table 138. Aurobindo Pharma Company Information

Table 139. Aurobindo Pharma Description and Major Businesses

Table 140. Aurobindo Pharma DTIs for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 141. Aurobindo Pharma DTIs for Injection Product Model Numbers, Pictures, Descriptions and Specifications

Table 142. Aurobindo Pharma Recent Developments

Table 143. GlaxoSmithKline Company Information

Table 144. GlaxoSmithKline Description and Major Businesses

Table 145. GlaxoSmithKline DTIs for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 146. GlaxoSmithKline DTIs for Injection Product Model Numbers, Pictures, Descriptions and Specifications

Table 147. GlaxoSmithKline Recent Developments

Table 148. Teva Pharmaceutical Company Information

Table 149. Teva Pharmaceutical Description and Major Businesses

Table 150. Teva Pharmaceutical DTIs for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 151. Teva Pharmaceutical DTIs for Injection Product Model Numbers, Pictures, Descriptions and Specifications

Table 152. Teva Pharmaceutical Recent Developments

Table 153. Eugia Pharma Company Information

Table 154. Eugia Pharma Description and Major Businesses

Table 155. Eugia Pharma DTIs for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 156. Eugia Pharma DTIs for Injection Product Model Numbers, Pictures, Descriptions and Specifications

Table 157. Eugia Pharma Recent Developments

Table 158. Dr.Reddy's Laboratories Company Information

Table 159. Dr.Reddy's Laboratories Description and Major Businesses

Table 160. Dr.Reddy's Laboratories DTIs for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 161. Dr.Reddy's Laboratories DTIs for Injection Product Model Numbers, Pictures, Descriptions and Specifications

Table 162. Dr.Reddy's Laboratories Recent Developments

Table 163. Yangtze River Pharmaceutical Company Information

Table 164. Yangtze River Pharmaceutical Description and Major Businesses

Table 165. Yangtze River Pharmaceutical DTIs for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 166. Yangtze River Pharmaceutical DTIs for Injection Product Model Numbers, Pictures, Descriptions and Specifications

Table 167. Yangtze River Pharmaceutical Recent Developments

Table 168. BrightGene Company Information

Table 169. BrightGene Description and Major Businesses

Table 170. BrightGene DTIs for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 171. BrightGene DTIs for Injection Product Model Numbers, Pictures, Descriptions and Specifications

Table 172. BrightGene Recent Developments

Table 173. Lunan Pharmaceutical Company Information

Table 174. Lunan Pharmaceutical Description and Major Businesses

Table 175. Lunan Pharmaceutical DTIs for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 176. Lunan Pharmaceutical DTIs for Injection Product Model Numbers, Pictures, Descriptions and Specifications

Table 177. Lunan Pharmaceutical Recent Developments

Table 178. CSPC Ouyi Pharmaceutical Company Information

Table 179. CSPC Ouyi Pharmaceutical Description and Major Businesses

Table 180. CSPC Ouyi Pharmaceutical DTIs for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 181. CSPC Ouyi Pharmaceutical DTIs for Injection Product Model Numbers, Pictures, Descriptions and Specifications

Table 182. CSPC Ouyi Pharmaceutical Recent Developments

Table 183. Beijing SL Pharmaceutical Company Information

Table 184. Beijing SL Pharmaceutical Description and Major Businesses

Table 185. Beijing SL Pharmaceutical DTIs for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 186. Beijing SL Pharmaceutical DTIs for Injection Product Model Numbers, Pictures, Descriptions and Specifications

Table 187. Beijing SL Pharmaceutical Recent Developments

Table 188. Key Raw Materials Lists

Table 189. Raw Materials Key Suppliers Lists

Table 190. DTIs for Injection Distributors List

Table 191. DTIs for Injection Customers List

Table 192. DTIs for Injection Market Trends

Table 193. DTIs for Injection Market Drivers

Table 194. DTIs for Injection Market Challenges

Table 195. DTIs for Injection Market Restraints

Table 196. Research Programs/Design for This Report

Table 197. Key Data Information from Secondary Sources

Table 198. Key Data Information from Primary Sources

List of Figures

Figure 1. DTIs for Injection Product Picture

Figure 2. Global DTIs for Injection Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global DTIs for Injection Market Share by Type: 2023 & 2030

Figure 4. Argatroban Product Picture

Figure 5. Bivalirudin Product Picture

Figure 6. Other Product Picture

Figure 7. Global DTIs for Injection Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 8. Global DTIs for Injection Market Share by Application: 2023 & 2030

Figure 9. Deep Vein Thrombosis

Figure 10. Pulmonary Embolism

Figure 11. Atrial Fibrillation

Figure 12. Other

Figure 13. DTIs for Injection Report Years Considered

Figure 14. Global DTIs for Injection Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 15. Global DTIs for Injection Revenue (2019-2030) & (US$ Million)

Figure 16. Global DTIs for Injection Revenue (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Figure 17. Global DTIs for Injection Revenue Market Share by Region in Percentage: 2023 Versus 2030

Figure 18. Global DTIs for Injection Revenue Market Share by Region (2019-2030)

Figure 19. Global DTIs for Injection Sales (2019-2030) & (K Units)

Figure 20. Global DTIs for Injection Sales (CAGR) by Region: 2019 VS 2023 VS 2030 (K Units)

Figure 21. Global DTIs for Injection Sales Market Share by Region (2019-2030)

Figure 22. US & Canada DTIs for Injection Sales YoY (2019-2030) & (K Units)

Figure 23. US & Canada DTIs for Injection Revenue YoY (2019-2030) & (US$ Million)

Figure 24. Europe DTIs for Injection Sales YoY (2019-2030) & (K Units)

Figure 25. Europe DTIs for Injection Revenue YoY (2019-2030) & (US$ Million)

Figure 26. China DTIs for Injection Sales YoY (2019-2030) & (K Units)

Figure 27. China DTIs for Injection Revenue YoY (2019-2030) & (US$ Million)

Figure 28. Asia (excluding China) DTIs for Injection Sales YoY (2019-2030) & (K Units)

Figure 29. Asia (excluding China) DTIs for Injection Revenue YoY (2019-2030) & (US$ Million)

Figure 30. Middle East, Africa and Latin America DTIs for Injection Sales YoY (2019-2030) & (K Units)

Figure 31. Middle East, Africa and Latin America DTIs for Injection Revenue YoY (2019-2030) & (US$ Million)

Figure 32. Global DTIs for Injection Sales Share by Manufacturers (2023)

Figure 33. The DTIs for Injection Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023

Figure 34. Global DTIs for Injection Revenue Share by Manufacturers (2023)

Figure 35. The Top 5 and 10 Largest Manufacturers of DTIs for Injection in the World: Market Share by DTIs for Injection Revenue in 2023

Figure 36. Global DTIs for Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 37. Global DTIs for Injection Sales Market Share by Type (2019-2030)

Figure 38. Global DTIs for Injection Revenue Market Share by Type (2019-2030)

Figure 39. Global DTIs for Injection Sales Market Share by Application (2019-2030)

Figure 40. Global DTIs for Injection Revenue Market Share by Application (2019-2030)

Figure 41. US & Canada DTIs for Injection Sales Market Share by Type (2019-2030)

Figure 42. US & Canada DTIs for Injection Revenue Market Share by Type (2019-2030)

Figure 43. US & Canada DTIs for Injection Sales Market Share by Application (2019-2030)

Figure 44. US & Canada DTIs for Injection Revenue Market Share by Application (2019-2030)

Figure 45. US & Canada DTIs for Injection Revenue Share by Country (2019-2030)

Figure 46. US & Canada DTIs for Injection Sales Share by Country (2019-2030)

Figure 47. US DTIs for Injection Revenue (2019-2030) & (US$ Million)

Figure 48. Canada DTIs for Injection Revenue (2019-2030) & (US$ Million)

Figure 49. Europe DTIs for Injection Sales Market Share by Type (2019-2030)

Figure 50. Europe DTIs for Injection Revenue Market Share by Type (2019-2030)

Figure 51. Europe DTIs for Injection Sales Market Share by Application (2019-2030)

Figure 52. Europe DTIs for Injection Revenue Market Share by Application (2019-2030)

Figure 53. Europe DTIs for Injection Revenue Share by Country (2019-2030)

Figure 54. Europe DTIs for Injection Sales Share by Country (2019-2030)

Figure 55. Germany DTIs for Injection Revenue (2019-2030) & (US$ Million)

Figure 56. France DTIs for Injection Revenue (2019-2030) & (US$ Million)

Figure 57. U.K. DTIs for Injection Revenue (2019-2030) & (US$ Million)

Figure 58. Italy DTIs for Injection Revenue (2019-2030) & (US$ Million)

Figure 59. Russia DTIs for Injection Revenue (2019-2030) & (US$ Million)

Figure 60. China DTIs for Injection Sales Market Share by Type (2019-2030)

Figure 61. China DTIs for Injection Revenue Market Share by Type (2019-2030)

Figure 62. China DTIs for Injection Sales Market Share by Application (2019-2030)

Figure 63. China DTIs for Injection Revenue Market Share by Application (2019-2030)

Figure 64. Asia DTIs for Injection Sales Market Share by Type (2019-2030)

Figure 65. Asia DTIs for Injection Revenue Market Share by Type (2019-2030)

Figure 66. Asia DTIs for Injection Sales Market Share by Application (2019-2030)

Figure 67. Asia DTIs for Injection Revenue Market Share by Application (2019-2030)

Figure 68. Asia DTIs for Injection Revenue Share by Region (2019-2030)

Figure 69. Asia DTIs for Injection Sales Share by Region (2019-2030)

Figure 70. Japan DTIs for Injection Revenue (2019-2030) & (US$ Million)

Figure 71. South Korea DTIs for Injection Revenue (2019-2030) & (US$ Million)

Figure 72. China Taiwan DTIs for Injection Revenue (2019-2030) & (US$ Million)

Figure 73. Southeast Asia DTIs for Injection Revenue (2019-2030) & (US$ Million)

Figure 74. India DTIs for Injection Revenue (2019-2030) & (US$ Million)

Figure 75. Australia DTIs for Injection Revenue (2019-2030) & (US$ Million)

Figure 76. Middle East, Africa and Latin America DTIs for Injection Sales Market Share by Type (2019-2030)

Figure 77. Middle East, Africa and Latin America DTIs for Injection Revenue Market Share by Type (2019-2030)

Figure 78. Middle East, Africa and Latin America DTIs for Injection Sales Market Share by Application (2019-2030)

Figure 79. Middle East, Africa and Latin America DTIs for Injection Revenue Market Share by Application (2019-2030)

Figure 80. Middle East, Africa and Latin America DTIs for Injection Revenue Share by Country (2019-2030)

Figure 81. Middle East, Africa and Latin America DTIs for Injection Sales Share by Country (2019-2030)

Figure 82. Brazil DTIs for Injection Revenue (2019-2030) & (US$ Million)

Figure 83. Mexico DTIs for Injection Revenue (2019-2030) & (US$ Million)

Figure 84. Turkey DTIs for Injection Revenue (2019-2030) & (US$ Million)

Figure 85. Israel DTIs for Injection Revenue (2019-2030) & (US$ Million)

Figure 86. GCC Countries DTIs for Injection Revenue (2019-2030) & (US$ Million)

Figure 87. DTIs for Injection Value Chain

Figure 88. DTIs for Injection Production Process

Figure 89. Channels of Distribution (Direct Vs Distribution)

Figure 90. Bottom-up and Top-down Approaches for This Report

Figure 91. Data Triangulation

Figure 92. Key Executives Interviewed